Mail

UK markets closed

FTSE 100
7,895.85
+18.80(+0.24%)
FTSE 250
19,391.30
-59.37(-0.31%)
AIM
745.67
+0.38(+0.05%)
GBP/EUR
1.1607
-0.0076(-0.65%)
GBP/USD
1.2370
-0.0068(-0.55%)
Bitcoin GBP
51,659.58
+2,091.49(+4.22%)

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Apollo Hospitals Enterprise Limited (APOLLOHOSP.NS)

NSE - NSE Real-time price. Currency in INR

Add to watchlist

6,169.55

+95.40

(+1.57%)

At close: 03:29PM IST

Currency in INR

Valuation measures⁴

Market cap (intra-day)	887.09B
Enterprise value	920.36B
Trailing P/E	112.38
Forward P/E	47.62
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	4.86
Price/book (mrq)	13.63
Enterprise value/revenue	5.04
Enterprise value/EBITDA	39.61

Trading information

Stock price history

Beta (5Y monthly)	0.56
52-week change ³	40.25%
S&P500 52-week change ³	20.07%
52-week high ³	6,874.45
52-week low ³	4,362.30
50-day moving average ³	6,352.68
200-day moving average ³	5,581.53

Share statistics

Avg vol (3-month) ³	522.95k
Avg vol (10-day) ³	396.57k
Shares outstanding ⁵	143.78M
Implied shares outstanding ⁶	146.14M
Float ⁸	97.71M
% held by insiders ¹	29.68%
% held by institutions ¹	47.14%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	15
Forward annual dividend yield ⁴	0.25%
Trailing annual dividend rate ³	15.00
Trailing annual dividend yield ³	0.25%
5-year average dividend yield ⁴	0.29
Payout ratio ⁴	27.32%
Dividend date ³	N/A
Ex-dividend date ⁴	20 Feb 2024
Last split factor ²	2:1
Last split date ³	02 Sept 2010

Financial highlights

Fiscal year

Fiscal year ends	31 Mar 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	4.29%
Operating margin (ttm)	9.21%

Management effectiveness

Return on assets (ttm)	N/A
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	184.18B
Revenue per share (ttm)	1,280.96
Quarterly revenue growth (yoy)	13.80%
Gross profit (ttm)	N/A
EBITDA	20.61B
Net income avi to common (ttm)	7.89B
Diluted EPS (ttm)	54.67
Quarterly earnings growth (yoy)	59.80%

Balance sheet

Total cash (mrq)	14.31B
Total cash per share (mrq)	99.55
Total debt (mrq)	48.89B
Total debt/equity (mrq)	71.08%
Current ratio (mrq)	N/A
Book value per share (mrq)	452.72

Cash flow statement

Operating cash flow (ttm)	N/A
Levered free cash flow (ttm)	N/A